X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (95) 95
nonmetastatic rhabdomyosarcoma (85) 85
oncology (85) 85
index medicus (77) 77
child (71) 71
male (60) 60
female (55) 55
rhabdomyosarcoma (53) 53
child, preschool (52) 52
adolescent (51) 51
chemotherapy (44) 44
pediatrics (39) 39
infant (38) 38
intergroup rhabdomyosarcoma (37) 37
international-society (37) 37
prognosis (35) 35
cancer (33) 33
prognostic-factors (33) 33
sarcoma (33) 33
surgery (32) 32
children (31) 31
pediatric-oncology (28) 28
rhabdomyosarcoma - therapy (28) 28
intergroup-rhabdomyosarcoma (27) 27
soft-tissue sarcoma (27) 27
childhood (26) 26
adult (25) 25
combined modality therapy (25) 25
treatment outcome (25) 25
tumors (25) 25
childrens oncology group (23) 23
radiotherapy (23) 23
study-iv (23) 23
retrospective studies (22) 22
hematology (21) 21
follow-up studies (20) 20
neoplasm staging (20) 20
rhabdomyosarcoma - pathology (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
disease-free survival (18) 18
survival rate (17) 17
young adult (17) 17
childhood rhabdomyosarcoma (16) 16
rhabdomyosarcoma - mortality (16) 16
risk factors (16) 16
soft-tissue sarcomas (16) 16
survival (16) 16
neoadjuvant chemotherapy (15) 15
nonmetastatic osteosarcoma (15) 15
osteosarcoma (15) 15
rhabdomyosarcoma - drug therapy (15) 15
hematology, oncology and palliative medicine (14) 14
patients (14) 14
prognostic factors (14) 14
abridged index medicus (13) 13
analysis (13) 13
care and treatment (13) 13
adolescence (12) 12
metastasis (12) 12
multivariate analysis (12) 12
research (12) 12
rhabdomyosarcoma - diagnosis (12) 12
rhabdomyosarcoma - radiotherapy (12) 12
rhabdomyosarcoma - surgery (12) 12
diagnosis (11) 11
metastatic rhabdomyosarcoma (11) 11
pediatric (11) 11
alveolar rhabdomyosarcoma (10) 10
bone neoplasms - drug therapy (9) 9
health aspects (9) 9
infant, newborn (9) 9
nonmetastatic ewings-sarcoma (9) 9
radiology, nuclear medicine & medical imaging (9) 9
soft tissue sarcoma (9) 9
age factors (8) 8
childhood-cancer (8) 8
embryonal rhabdomyosarcoma (8) 8
kaplan-meier estimate (8) 8
of-pediatric-oncology (8) 8
rhabdomyosarcoma, alveolar - mortality (8) 8
time factors (8) 8
3rd (7) 7
adjuvant chemotherapy (7) 7
article (7) 7
bone cancer (7) 7
clinical trials as topic (7) 7
incidence (7) 7
medicine & public health (7) 7
middle aged (7) 7
neoplasm recurrence, local - mortality (7) 7
neoplasms (7) 7
patient outcomes (7) 7
phase-ii window (7) 7
preoperative chemotherapy (7) 7
proportional hazards models (7) 7
radiation therapy (7) 7
radiation-therapy (7) 7
radiotherapy dosage (7) 7
rhabdomyosarcoma - genetics (7) 7
sarcoma - therapy (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2151 - 2158
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 635 - 642
Purpose To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Conformal radiotherapy | Late effects | Proton radiotherapy | Parameningeal rhabdomyosarcoma | Pediatric | NECK RHABDOMYOSARCOMA | HEAD | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | INTENSITY-MODULATED RADIOTHERAPY | NONMETASTATIC RHABDOMYOSARCOMA | SOFT-TISSUE | CHILDREN | CHILDHOOD-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Follow-Up Studies | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Radiotherapy - adverse effects | Organ Sparing Treatments - methods | Rhabdomyosarcoma - radiotherapy | Meningeal Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - mortality | Massachusetts | Female | Rhabdomyosarcoma - drug therapy | Child | Rhabdomyosarcoma - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - radiotherapy | Treatment Outcome | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Meningeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy | Medical colleges | Nuclear radiation | DIAGNOSIS | PATIENTS | NEOPLASMS | FAILURES | PHOTONS | TEETH | RADIATION DOSES | CARIES | HISTOLOGY | PROTONS | SINUSES | MEDICAL RECORDS | NOSE | RADIATION DOSE UNITS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIOTHERAPY | SIDE EFFECTS | COBALT | CONTROL
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 1070 - 1077
Journal Article
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2018, Volume 124, Issue 15, pp. 3201 - 3209
BACKGROUND Alveolar rhabdomyosarcoma (aRMS) with lymph node involvement (N1 classification) accounts for up to 10% of all cases of RMS. The prognosis is poor,... 
paired box (PAX)‐forkhead box protein O1 (FOXO1) fusion | prognostic factors | rhabdomyosarcoma | alveolar rhabdomyosarcoma | lymph node involvement | paired box (PAX)-forkhead box protein O1 (FOXO1) fusion | TRANSLOCATIONS | METASTATIC RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | PAX3-FKHR FUSION | CHILDHOOD | CHILDRENS ONCOLOGY GROUP | GENE | ONCOLOGY | Pediatrics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymph Nodes - pathology | Prognosis | Lymph Nodes - surgery | Humans | Child, Preschool | Neoplasm Recurrence, Local - drug therapy | Infant | Male | Neoplasm Recurrence, Local - pathology | Young Adult | Adult | Female | Lymph Nodes - drug effects | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - genetics | Risk Factors | Lymphatic Metastasis | Disease-Free Survival | Rhabdomyosarcoma, Alveolar - epidemiology | Adolescent | Neoplasm Recurrence, Local - genetics | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Forkhead Box Protein O1 - genetics | Medical services | Rhabdomyosarcoma | Event-related potentials | Multivariate analysis | Neoplasms | Lymph nodes | Metastases | Proteins | FOXO1 protein | Surgery | Forkhead protein | Alveoli | Lymphatic system | Sarcoma | Invasiveness | Medical treatment | Soft tissue sarcoma | Radiation therapy | Patients | Chemotherapy | Biopsy | Medical prognosis | Cancer | Tumors | Lymph
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1670 - 1677
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 07/2017, Volume 64, Issue 7, p. n/a
Background Long‐term toxicities from current treatments are a major issue in paediatric cancer. Previous studies, including our own, have shown prognostic... 
risk stratification | fusion gene | histology | rhabdomyosarcoma | molecular classification | survival | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | NONMETASTATIC RHABDOMYOSARCOMA | CHILDRENS ONCOLOGY GROUP | PEDIATRIC RHABDOMYOSARCOMA | CHILDHOOD-CANCER | ONCOLOGY | EMBRYONAL RHABDOMYOSARCOMA | SARCOMAS | ALVEOLAR RHABDOMYOSARCOMA | PEDIATRICS | HEMATOLOGY | EXPRESSION | Paired Box Transcription Factors - genetics | Biomarkers, Tumor - analysis | Tissue Array Analysis | Humans | Risk Factors | Child, Preschool | Rhabdomyosarcoma - pathology | In Situ Hybridization, Fluorescence | Male | United Kingdom | Clinical Trials as Topic | Reverse Transcriptase Polymerase Chain Reaction | Oncogene Proteins, Fusion - genetics | Soft Tissue Neoplasms - classification | Soft Tissue Neoplasms - pathology | Rhabdomyosarcoma - classification | Female | Retrospective Studies | Rhabdomyosarcoma - genetics | Child | Research Design | Soft Tissue Neoplasms - genetics | Sarcoma | Oncology, Experimental | Genes | Stem cells | Research | Genetic transcription | Metastasis | Cancer | Mesenchyme | Toxicity | Rhabdomyosarcoma | Clinical trials | Fluorescence | Reverse transcription | Risk | Recruitment | Metastases | FOXO1 protein | Toxicity testing | Pax3 protein | Alveoli | Fusion protein | Medical research | Risk groups | Health risks | Soft tissue sarcoma | Histology | Patients | Survival | Reclassification | Quality of life | Polymerase chain reaction | Tumors | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 09/2018, Volume 36, Issue 27, pp. 2770 - 2770
PurposeIntermediate-risk rhabdomyosarcoma (RMS) includes patients with either nonmetastatic, unresected embryonal RMS (ERMS) with an unfavorable primary site... 
PEDIATRIC RHABDOMYOSARCOMA | STUDY-IV | ONCOLOGY | TISSUE SARCOMA COMMITTEE | PHASE-II WINDOW | METASTATIC RHABDOMYOSARCOMA | EMBRYONAL RHABDOMYOSARCOMA | CLINICAL-TRIALS | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | RADIOTHERAPY | Index Medicus
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 11/2019, Volume 66, Issue 11, pp. e27932 - n/a
Purpose The presence of pleural effusion or ascites at the time of diagnosis is generally considered a poor prognostic factor for children with... 
ascites | pleural effusion | rhabdomyosarcoma | SURVIVAL | ONCOLOGY | SARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | PEDIATRICS | SOFT-TISSUE | HEMATOLOGY | CHILDREN | Sarcoma | Effusion | Rhabdomyosarcoma | Soft tissue sarcoma | Pleural effusion | Radiation therapy | Patients | Soft tissues | Confidence intervals | Chemotherapy | Surgery | Children | Diagnosis | Ascites
Journal Article